Company Filing History:
Years Active: 2016-2019
Title: Innovations in Liquid Compositions by Inventor Balaram Mondal
Introduction
Balaram Mondal, an innovative inventor based in East Midnapore, India, has made significant contributions to the pharmaceutical field. With a total of four patents to his name, he has developed formulations that enhance the delivery and effectiveness of guanfacine, a medication often used for attention deficit hyperactivity disorder (ADHD) and hypertension.
Latest Patents
His latest patents focus on extended release and oral liquid compositions of guanfacine. The first patent describes the production of extended release liquid compositions that are bioequivalent to marketed extended release tablet forms. These compositions maintain a consistent in-vitro dissolution release profile for at least seven days and are characterized by their stability. They can be formulated as ready-to-use or reconstituted liquids, thus providing flexibility in administration.
The second patent relates to oral liquid compositions of guanfacine, which can either be immediate release or extended release types. These compositions contain guanfacine at concentrations ranging from approximately 0.1 mg/mL to about 12.0 mg/mL and can be created as ready-to-use or reconstituted liquids, once again emphasizing the practical applications of his inventions.
Career Highlights
Balaram Mondal is associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at this esteemed organization has enabled him to pioneer advancements in medication formulation, specifically targeting liquid compositions that provide enhanced therapeutic benefits.
Collaborations
Mondal collaborates closely with talented professionals in his field, including coworkers Kalaiselvan Ramaraju and Romi Barat Singh. This collaborative environment fosters creativity and innovation, allowing them to push the boundaries of pharmaceutical development.
Conclusion
Balaram Mondal's contributions to the field of pharmaceutical sciences underscore the importance of innovation in improving medication delivery methods. His patents on guanfacine liquid compositions highlight his commitment to enhancing treatment options for patients, making him a notable inventor in today’s pharmaceutical landscape.